News + Filings Transactions
|
Salter Malcolm
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | C4 Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 26k | $3.61 | $93.9k | | 06/15/2023 |
| 06/22/2022 | C4 Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 23.5k | $6.06 | $142.4k | | 06/22/2022 |
| 01/04/2022 | C4 Therapeutics, Inc. | | Grant | Common Stock | 428 | $31.58 | $13.5k | | 01/04/2022 |
| 12/17/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $30.25 | $22.8k | | 12/17/2021 |
| 11/19/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $40.11 | $30.3k | | 11/19/2021 |
| 10/15/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $44.94 | $33.9k | | 10/15/2021 |
| 10/04/2021 | C4 Therapeutics, Inc. | | Grant | Common Stock | 300 | $44.99 | $13.5k | | 10/04/2021 |
| 09/17/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $49.89 | $37.7k | | 09/17/2021 |
| 08/20/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $40.73 | $30.8k | | 08/20/2021 |
| 07/16/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $37.37 | $28.2k | | 07/16/2021 |
| 07/02/2021 | C4 Therapeutics, Inc. | | Grant | Common Stock | 339 | $39.72 | $13.5k | | 07/02/2021 |
| 06/18/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $37.19 | $28.1k | | 06/18/2021 |
| 06/15/2021 | C4 Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 23.5k | $37.66 | $885k | | 06/15/2021 |
| 05/21/2021 | C4 Therapeutics, Inc. | | Sale | Common Stock | 755 | $37.12 | $28k | | 05/21/2021 |
| 04/05/2021 | C4 Therapeutics, Inc. | | Grant | Common Stock | 359 | $37.51 | $13.5k | | 04/05/2021 |
| 10/06/2020 | C4 Therapeutics, Inc. | | Conversion | Common Stock | 11.9k | $0.00 | $0 | | 10/06/2020 |
| 10/06/2020 | C4 Therapeutics, Inc. | | Conversion | Common Stock | 2.8k | $0.00 | $0 | | 10/06/2020 |
| 10/06/2020 | C4 Therapeutics, Inc. | | Purchase | Common Stock | 1.3k | $19.00 | $25k | | 10/06/2020 |
| 10/06/2020 | C4 Therapeutics, Inc. | | Conversion | Series A Preferred Stock | 100k | $0.00 | $0 | | 10/06/2020 |
| 10/06/2020 | C4 Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 23.8k | $0.00 | $0 | | 10/06/2020 |
| 10/01/2020 | C4 Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 17.8k | $19.00 | $337.9k | | 10/01/2020 |
|